Copeland Capital Management’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Sell
640,051
-439,538
-41% -$11.5M 0.29% 106
2026
Q1
$29.5M Sell
1,079,589
-9,333
-0.9% -$331K 0.66% 59
2025
Q4
$45.3M Sell
1,088,922
-121,558
-10% -$4.93M 1.01% 39
2025
Q3
$55.9M Sell
1,210,480
-60,645
-5% -$3.24M 1.16% 33
2025
Q2
$67.2M Sell
1,271,125
-102,307
-7% -$5.4M 1.38% 22
2025
Q1
$76.4M Buy
1,373,432
+40,226
+3% +$1.93M 1.53% 13
2024
Q4
$57.7M Buy
1,333,206
+329,831
+33% +$14.7M 1.07% 39
2024
Q3
$51.4M Buy
1,003,375
+17,653
+2% +$1.18M 0.89% 50
2024
Q2
$62.4M Buy
985,722
+110,750
+13% +$6.65M 1.17% 33
2024
Q1
$57.9M Buy
874,972
+464,227
+113% +$37.7M 1.05% 43
2023
Q4
$40.3M Buy
+410,745
New +$35.8M 0.81% 54

Other funds holding CNXC

Copeland Capital Management's CNXC Position: Q2 2026 in Review

Copeland Capital Management reduced its Concentrix (CNXC) stake by 41% in Q2 2026, selling an estimated $11.5M and leaving 640,051 shares worth $14.3M. The position accounts for 0.29% of the portfolio, ranked #106.

Copeland Capital Management first reported a position in CNXC in Q4 2023 and has held it in 11 quarters since. The position peaked at $76.4M in Q1 2025. 271 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Copeland Capital Management held 640,051 shares of Concentrix worth $14.3M as of Q2 2026.
  • Copeland Capital Management sold 439,538 Concentrix shares in Q2 2026, an estimated $11.5M.
  • Concentrix made up 0.29% of Copeland Capital Management's portfolio in Q2 2026, its #106 holding.
  • Copeland Capital Management first reported a position in Concentrix in Q4 2023 and has held it in 11 quarters since.
  • Copeland Capital Management's Concentrix position peaked at $76.4M in Q1 2025.
  • 271 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Copeland Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.